Well, off-label, actually:
I've been asked how carriers might handle the off-label use of meds like Chloroquine (generally used as an anti-malarial drug, and also for lupus) . That is, would this "off-label use" still be considered a valid/covered expense?
To that end, I've reached out to one of our carriers (and been trying to do so with others) to see how this issue has historically been addressed. By way of example, I've posed this:
I've been asked how carriers might handle the off-label use of meds like Chloroquine (generally used as an anti-malarial drug, and also for lupus) . That is, would this "off-label use" still be considered a valid/covered expense?
To that end, I've reached out to one of our carriers (and been trying to do so with others) to see how this issue has historically been addressed. By way of example, I've posed this:
"Researching a post on how carriers *might* handle use of chloroquine for COVID-19. NOT asking how y'all will handle that issue specifically, but just how/if cover off-label use of meds for medically-necessary issues. For example, using Colchicine (gout med) for Pericarditis (pericardium inflammation). *In general*, is this kind of thing usually covered?"
So far, I've been kicked up the food chain, but still awaiting an on-point response.
If you are in a position (or know someone who is) to help us with an answer, I would be very grateful for your help. And, of course, confidentiality is a given.